141 related articles for article (PubMed ID: 19099510)
1. Identification of a new G-quadruplex motif in the KRAS promoter and design of pyrene-modified G4-decoys with antiproliferative activity in pancreatic cancer cells.
Cogoi S; Paramasivam M; Filichev V; Géci I; Pedersen EB; Xodo LE
J Med Chem; 2009 Jan; 52(2):564-8. PubMed ID: 19099510
[TBL] [Abstract][Full Text] [Related]
2. G-rich oligonucleotide inhibits the binding of a nuclear protein to the Ki-ras promoter and strongly reduces cell growth in human carcinoma pancreatic cells.
Cogoi S; Quadrifoglio F; Xodo LE
Biochemistry; 2004 Mar; 43(9):2512-23. PubMed ID: 14992588
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative activity of a triplex-forming oligonucleotide recognizing a Ki-ras polypurine/polypyrimidine motif correlates with protein binding.
Cogoi S; Ballico M; Bonora GM; Xodo LE
Cancer Gene Ther; 2004 Jul; 11(7):465-76. PubMed ID: 15118760
[TBL] [Abstract][Full Text] [Related]
4. The effect of INA [(R)-1-O-(1-pyrenylmethyl)glycerol] insertions on the structure and biological activity of a G-quadruplex from a critical KRAS G-rich sequence.
Cogoi S; Paramasivan M; Xodo LE; Filichev VV; Pedersen EB
Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1641-3. PubMed ID: 18066843
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the equilibrium between G-quadruplex and duplex DNA in promoter of human c-myc oncogene by a pyrene derivative.
Zhang Z; He X; Yuan G
Int J Biol Macromol; 2011 Dec; 49(5):1173-6. PubMed ID: 21683090
[TBL] [Abstract][Full Text] [Related]
6. MAZ-binding G4-decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice.
Cogoi S; Zorzet S; Rapozzi V; Géci I; Pedersen EB; Xodo LE
Nucleic Acids Res; 2013 Apr; 41(7):4049-64. PubMed ID: 23471001
[TBL] [Abstract][Full Text] [Related]
7. Protein hnRNPA1 binds to a critical G-rich element of KRAS and unwinds G-quadruplex structures: implications in transcription.
Xodo L; Paramasivam M; Membrino A; Cogoi S
Nucleic Acids Symp Ser (Oxf); 2008; (52):159-60. PubMed ID: 18776302
[TBL] [Abstract][Full Text] [Related]
8. Novel molecular mechanism for actinomycin D activity as an oncogenic promoter G-quadruplex binder.
Kang HJ; Park HJ
Biochemistry; 2009 Aug; 48(31):7392-8. PubMed ID: 19496619
[TBL] [Abstract][Full Text] [Related]
9. Interactions of sodium and potassium ions with oligonucleotides carrying human telomeric sequence and pyrene moieties at both termini.
Hayashida H; Paczesny J; Juskowiak B; Takenaka S
Bioorg Med Chem; 2008 Nov; 16(22):9871-81. PubMed ID: 18851918
[TBL] [Abstract][Full Text] [Related]
10. G4-DNA formation in the HRAS promoter and rational design of decoy oligonucleotides for cancer therapy.
Membrino A; Cogoi S; Pedersen EB; Xodo LE
PLoS One; 2011; 6(9):e24421. PubMed ID: 21931711
[TBL] [Abstract][Full Text] [Related]
11. 9-N-Substituted berberine derivatives: stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc.
Ma Y; Ou TM; Hou JQ; Lu YJ; Tan JH; Gu LQ; Huang ZS
Bioorg Med Chem; 2008 Aug; 16(16):7582-91. PubMed ID: 18674916
[TBL] [Abstract][Full Text] [Related]
12. G-Quadruplex Supramolecular Assemblies in Photochemical Upconversion.
Mutsamwira S; Ainscough EW; Partridge AC; Derrick PJ; Filichev VV
Chemistry; 2016 Jul; 22(30):10376-81. PubMed ID: 27172273
[TBL] [Abstract][Full Text] [Related]
13. Structural polymorphism within a regulatory element of the human KRAS promoter: formation of G4-DNA recognized by nuclear proteins.
Cogoi S; Paramasivam M; Spolaore B; Xodo LE
Nucleic Acids Res; 2008 Jun; 36(11):3765-80. PubMed ID: 18490377
[TBL] [Abstract][Full Text] [Related]
14. Effects of triethylene tetraamine on the G-quadruplex structure in the human c-myc promoter.
Yin F; Liu J; Deng X; Wang J
J Biochem; 2007 May; 141(5):669-74. PubMed ID: 17339229
[TBL] [Abstract][Full Text] [Related]
15. Quadruplex-duplex competition in the nuclease hypersensitive element of human c-myc promoter: C to T mutation in C-rich strand enhances duplex association.
Halder K; Mathur V; Chugh D; Verma A; Chowdhury S
Biochem Biophys Res Commun; 2005 Feb; 327(1):49-56. PubMed ID: 15629428
[TBL] [Abstract][Full Text] [Related]
16. G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription.
Cogoi S; Xodo LE
Nucleic Acids Res; 2006; 34(9):2536-49. PubMed ID: 16687659
[TBL] [Abstract][Full Text] [Related]
17. Primer extension reactions as a tool to uncover folding motifs within complex G-rich sequences: analysis of the human KRAS NHE.
Paramasivam M; Cogoi S; Xodo LE
Chem Commun (Camb); 2011 May; 47(17):4965-7. PubMed ID: 21424008
[TBL] [Abstract][Full Text] [Related]
18. Purine twisted-intercalating nucleic acids: a new class of anti-gene molecules resistant to potassium-induced aggregation.
Paramasivam M; Cogoi S; Filichev VV; Bomholt N; Pedersen EB; Xodo LE
Nucleic Acids Res; 2008 Jun; 36(10):3494-507. PubMed ID: 18456705
[TBL] [Abstract][Full Text] [Related]
19. Repression of translation of human estrogen receptor alpha by G-quadruplex formation.
Balkwill GD; Derecka K; Garner TP; Hodgman C; Flint AP; Searle MS
Biochemistry; 2009 Dec; 48(48):11487-95. PubMed ID: 19860473
[TBL] [Abstract][Full Text] [Related]
20. KRAS promoter oligonucleotide with decoy activity dimerizes into a unique topology consisting of two G-quadruplex units.
Podbevšek P; Plavec J
Nucleic Acids Res; 2016 Jan; 44(2):917-25. PubMed ID: 26656490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
